StockGlow

Clinuvel Pharmaceuticals Limited (UR9.F)

Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

5.50-0.05%Healthcare
Compare UR9.F with
StockGlow Score
12
Bearish
BearishBullish
1 year ago-23.6%

The outlook

Clinuvel Pharmaceuticals Limited currently reads as bearish based on below its 50- & 200-day averages, 16% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range16% of the way from its 52-week low to high
Market cap
$277.4M
52-wk high
7.68
52-wk low
5.10
50-day avg
5.76
200-day avg
6.16
Trailing P/E
14.1

Similar stocks

CUV.AXClinuvel Pharmaceuticals Limited$9.06-2.48%CUVLClinuvel Pharmaceuticals Limited$6.93+1.54%VNRXVolitionRx Limited$0.80+3.51%CLVLFClinuvel Pharmaceuticals Limited$6.37+0.00%UR9.SGClinuvel Pharmaceuticals Ltd$5.68-1.08%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy